Vinayak Hosagrahara
About Vinayak Hosagrahara
Vinayak Hosagrahara serves as the Executive Director of DMPK at Nimbus Therapeutics, where he has worked since 2021. He holds a Ph.D. in Medicinal Chemistry from the University of Minnesota and has extensive experience in drug metabolism and pharmacokinetics across several prominent pharmaceutical companies.
Current Position at Nimbus Therapeutics
Vinayak Hosagrahara serves as the Executive Director of DMPK at Nimbus Therapeutics. He has held this position since 2021, contributing to the company's drug metabolism and pharmacokinetics (DMPK) strategies. His role involves overseeing DMPK operations and ensuring the integration of pharmacokinetic principles into the drug development process.
Previous Experience in Pharmaceutical Industry
Vinayak Hosagrahara has extensive experience in the pharmaceutical industry. He worked at Novartis Institutes for Biomedical Research as Laboratory Head from 2006 to 2011. He then joined AstraZeneca, where he held multiple roles, including Director of DMPK and Site Head of DMPK in Bangalore, India. His tenure at AstraZeneca spanned from 2011 to 2016, during which he also served as Biotransformation Team Lead. Prior to these roles, he was a Research Investigator at Bristol-Myers Squibb from 2000 to 2006.
Educational Background in Medicinal Chemistry
Vinayak Hosagrahara earned his Ph.D. in Medicinal Chemistry from the University of Minnesota. He also holds a Bachelor of Pharmacy degree from the Bombay College of Pharmacy in Mumbai. His educational background has provided a strong foundation for his career in drug development and research.
Research and Development Contributions
Throughout his career, Vinayak Hosagrahara has made significant contributions to research and development in the pharmaceutical sector. His roles have involved leading teams and projects focused on drug discovery and development, particularly in the areas of DMPK and biotransformation. His expertise has been instrumental in advancing therapeutic candidates from early discovery through clinical development.